Nurix Therapeutics (NRIX) Return on Assets (2020 - 2026)

Nurix Therapeutics (NRIX) has 7 years of Return on Assets data on file, last reported at 0.0% in Q1 2026.

• Return on Assets for Q1 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Feb 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Assets declined to 0.0% in Q1 2026 per NRIX's latest filing, from 0.0% in the prior quarter.
• Over five years, Return on Assets peaked at 0.0% in Q1 2022 and troughed at 0.0% in Q1 2023.
• A 5-year average of 0.0% and a median of 0.0% in 2022 frame the typical range for Return on Assets.
• On a YoY basis, Return on Assets climbed as much as 0 bps in 2022 and fell as far as 0 bps in 2022.
• A 5-year view of Return on Assets shows it stood at 0.0% in 2022, then declined by 5 bps to 0.0% in 2023, then increased by 25 bps to 0.0% in 2024, then sank by 33 bps to 0.0% in 2025, then dropped by 2 bps to 0.0% in 2026.
• Business Quant data shows NRIX's Return on Assets at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.